The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Prevalence of Vertebral Fractures in Men with Acromegaly
Abstract
Context Data on osteoporotic fractures in acromegaly are limited. An increased prevalence of radiological vertebral fractures was already observed in postmenopausal women with active acromegaly. It is unknown whether this observation may reflect a more general increased risk of fractures in acromegaly. Design This was a cross-sectional study. Setting The study was conducted at referral centers. Patients and control subjects Subjects included 40 males with acromegaly (25 patients with controlled disease and 15 patients with active disease) and 31 control males, with age and gonadal status comparable with the patients. Interventions Evaluation of vertebral fractures (quantitative morphometric analysis) and bone mineral density (BMD) at lumbar spine and total hip (dual energy X-ray absorptiometry) was done. Main outcome measure Vertebral fractures were assessed. Results Although BMD was not significantly different between acromegalic patients and control subjects, the prevalence of vertebral fractures was higher in acromegalic patients as compared with the control subjects (57.5 vs. 22.6%; chi(2): 8.7; P = 0.003). Fractured and nonfractured acromegalic patients showed no significant difference in age and BMD Z-score. However, acromegalic patients with fractures had serum IGF-I values significantly higher and duration of active disease significantly longer with respect to patients without fractures. Moreover, patients with fractures showed significantly longer untreated hypogonad…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hypogonadal patients with acromegaly are at higher risk of osteoporosis, particularly at sites composed predominantly of trabecular bone, which has more intimate contact with the circulation and is influenced by sex steroids to a greater extent [34, 39, 40].”
From Pituitary Disorders and Osteoporosis (2015) · cites this paper as [39]
In the citing paper
“which makes BMD a poor fracture predictor [27, 30, 39, 42].”
From Pituitary Disorders and Osteoporosis (2015) · cites this paper as [39]
In the citing paper
“Patients with acromegaly have an increased risk of fractures, which might be correlated with insufficient quality of bone [26, 27, 39, 42].”
From Pituitary Disorders and Osteoporosis (2015) · cites this paper as [39]
In the citing paper
“Vertebral fractures may be present in patients with normal or slightly decreased BMD, which makes BMD a poor fracture predictor [27, 30, 39, 42].”
From Pituitary Disorders and Osteoporosis (2015) · cites this paper as [39]
Citations
Cites
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824
Vestergaard, P. F. (2006) · Osteoporosis International · doi:10.1007/s00198-006-0253-4 · Cited by 1,803
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
Colao, A. A. L., Ferone, D., Marzullo, P., & Lombardi, G. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0022 · Cited by 1,313
Giustina, A., & Veldhuis, J. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0353 · Cited by 1,253
Self-citationTang, B. M., Eslick, G. D., Nowson, C., Smith, C., & Bensoussan, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61342-7 · Cited by 1,248
Glucocorticoid-induced osteoporosis: pathophysiology and therapy
CANALIS, E. M., Mazziotti, G., Giustina, A., & Bilezikian, J. P. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0394-0 · Cited by 1,131
Self-citationCriteria for Cure of Acromegaly: A Consensus Statement
Giustina, A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.526 · Cited by 996
Self-citationGrowth Hormone, Insulin-Like Growth Factors, and the Skeleton
Giustina, A., Mazziotti, G., & CANALIS, E. M. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0036 · Cited by 932
Self-citationMechanisms of Anabolic Therapies for Osteoporosis
CANALIS, E. M., Giustina, A., & Bilezikian, J. P. (2007) · New England Journal of Medicine · doi:10.1056/nejmra067395 · Cited by 675
Self-citationGenant, H. K., Jergas, M. D., Palermo, L., Nevitt, M. C., Valentin, R. S., Black, D. M., & Cummings, S. R. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110716 · Cited by 637
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–169 of 169
Osteoporosis Associated with Illnesses and Medications
Shane, E. J., & Marcus, R. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00048-0 · Cited by 10
Jawiarczyk-Przybyłowska, A., Halupczok-Żyła, J., Syrycka, J., Zembska, A., Kuliczkowska-Płaksej, J., & Bolanowski, M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.862845 · Cited by 8
Pontes, J., Madeira, M., Lima, C. H. D. A., Ogino, L. L., Paranhos‐Neto, F. D. P., de Mendonça, L. M. C., Farias, M. L. F., Kasuki, L., & Gadelha, M. R. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01096-5 · Cited by 9
Glucocorticoid-induced Osteoporosis
Mazziotti, G., & Giustina, A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374602-3.00034-1 · Cited by 9
Self-citationLow sclerostin levels after long-term remission of acromegaly
Claessen, K. M. J. A., Pelsma, I. C. M., Kroon, H. M. J. A., van Lierop, A. H., Pereira, A. M., Biermasz, N. R., & Appelman‐Dijkstra, N. M. (2021) · Endocrine · doi:10.1007/s12020-021-02850-7 · Cited by 8
Chiloiro, S., Mirra, F., Donfrancesco, F., Giampietro, A., Visconti, F., Rossi, L., Pontecorvi, A., Marinis, L. D., & Bianchi, A. (2020) · Protein and Peptide Letters · doi:10.2174/0929866527666200616151105 · Cited by 8
Self-citationFrara, S., Uygur, M. M., Bolamperti, F. M., di Filippo, L., Doga, M., Ferrari, F., Losa, M., Mortini, P., & Giustina, A. (2024) · Pituitary · doi:10.1007/s11102-024-01394-z · Cited by 7
Self-citationHeck, A., Godang, K., Lekva, T., Markussen, K. N., Vincentis, S. D., Ueland, T., & Bollerslev, J. (2023) · JBMR Plus · doi:10.1002/jbm4.10787 · Cited by 7
The effects of high serum growth hormone and IGF-1 levels on bone mineral density in acromegaly
Tuzcu, Ş. A., Durmaz, Ş. A., Çarlıoğlu, A., Demircan, Z., Tuzcu, A., Beyaz, C., & Tay, A. (2016) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-016-0171-6 · Cited by 7
Acromegaly complications: an update
Giustina, A., & Fleseriu, M. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag114 · Cited by 6
Self-citationDiagnosis and therapeutic approach to bone health in patients with hypopituitarism
Kuliczkowska-Płaksej, J., Zdrojowy-Wełna, A., Jawiarczyk-Przybyłowska, A., Gojny, Ł., & Bolanowski, M. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09878-w · Cited by 6
Novel approach to bone comorbidity in resistant acromegaly
Frara, S., Acanfora, M., Franzese, V., Brandi, M. L., Losa, M., & Giustina, A. (2024) · Pituitary · doi:10.1007/s11102-024-01468-y · Cited by 7
Self-citationOsteosarcopenia in acromegaly: reduced muscle quality and increased vertebral fat deposition
Eroğlu, İ., İremli, B. G., Erkoç, A., İdilman, İ. S., Yüce, D., Calik-Kutukcu, E., Akata, D., & Erbas, T. A. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02114-3 · Cited by 6
Kuker, A. P., Agarwal, S., Shane, E. J., Bicca, J. M., Geer, E. B., Cremers, S., Dworakowski, E., Cohen, A., Nickolas, T. L., Stein, E. M., et al. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae079 · Cited by 6
Dixit, M., Louis, L. D., Basta‐Pljakic, J., Yildirim, G., Poudel, S., Kumararaja, F., List, E. O., Duran, S. O., Kopchick, J. J., Ruff, R. R., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4699 · Cited by 5
Osteoporosis in pituitary diseases: lessons for the clinic
Bolanowski, M., Jawiarczyk-Przybyłowska, A., & Halupczok-Żyła, J. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.983473 · Cited by 5
Bone and joint structural impairments in acromegaly
Тамерланович, Ц. Т., & Belaya, Z. E. (2018) · Problems of Endocrinology · doi:10.14341/probl9305 · Cited by 5
Multiple Endocrine Neoplasia Syndromes
Newey, P. J., & Thakker, R. V. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804182-6.00038-1 · Cited by 5
Acromegaly treatment and bone: a bidirectional relationship
Chiloiro, S., Palumbo, C., Giampietro, A., Marinis, L. D., Bianchi, A., Giustina, A., & Pontecorvi, A. (2025) · Pituitary · doi:10.1007/s11102-025-01573-6 · Cited by 4
Self-citationFreda, P. U. (2023) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2023.101824 · Cited by 4
Impact of medical therapy for hormone-secreting Pituitary tumors on bone
Freda, P. U. (2024) · Pituitary · doi:10.1007/s11102-024-01421-z · Cited by 4
Sclerostin and OPG/RANK-L system take part in bone remodeling in patients with acromegaly
Halupczok-Żyła, J., Jawiarczyk-Przybyłowska, A., & Bolanowski, M. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1472680 · Cited by 5
Outcome of complications in acromegaly patients after long-term disease remission
Claessen, K. M. J. A., Pereira, A. M., & Biermasz, N. R. (2015) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.1068116 · Cited by 4
Rheumatic manifestations of acromegaly
Паневин, Т. С., Алексеева, Л. И., & Mel'nichenko, G. A. (2020) · Osteoporosis and Bone Diseases · doi:10.14341/osteo11353 · Cited by 3
Giustina, A. (2011) · Endocrine · doi:10.1007/s12020-011-9448-3 · Cited by 4
Self-citationGrowth hormone, insulin-like growth factors, and IGF binding proteins
Rosen, C. J., & Yakar, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00042-7 · Cited by 3
Tamada, D., Kitamura, T., Takahara, M., Oshino, S., Saitoh, Y., Otsuki, M., & Shimomura, I. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej15-0174 · Cited by 3
Acromégalie : améliorer la prise en charge
Mosbah, H., Brue, T. C., & Chanson, P. (2019) · Annales d Endocrinologie · doi:10.1016/s0003-4266(19)30112-x · Cited by 3
Dytz, O. D. C., Berger, P. D. A., Dytz, M. G., Barbosa, B. A., Jreige, A., Reggatieri, N. A. T., Disegna, A., de Paula, W. D., Casulari, L. A., & Naves, L. A. (2020) · Endocrine · doi:10.1007/s12020-020-02358-6 · Cited by 2
Maione, L., & Chanson, P. (2022) · Springer eBooks · doi:10.1007/978-3-030-90475-3_5 · Cited by 3
Influence of disease activity and gonadal status on bone mineral density and turnover in acromegaly
Silva, F. F., Lima, M. D. L., Pedreira, C. C., & Matos, M. A. (2024) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-024-01561-z · Cited by 2
Intervertebral disc degeneration is accelerated by GH overexpression but attenuated by GH antagonism
Sukul, A., Ren, S., Miller, A. E., Liu, H., Akande, O. I., Tang, S. Y., O’Connor, P. M., Kopchick, J. J., & Zhu, S. (2025) · GeroScience · doi:10.1007/s11357-025-02022-9 · Cited by 2
Consensus on the change of criteria for cure of acromegaly during the last decade
Kovács, G. L., Dénes, J., Hubina, E., Kovács, L., Czirják, S., & Góth, M. (2011) · Orvosi Hetilap · doi:10.1556/oh.2011.29092 · Cited by 2
Ostéoarthropathies d'origine endocrinienne
Lambert, A.-S., Loffroy, R., Feydy, A., Thévenin, F., Merzoug, V., Méjean, N., Couaillier, J. F., Barral, F.-G., Chevrot, A., Drapé, J., et al. (2011) · EMC - Radiologie et imagerie médicale - Musculosquelettique - Neurologique - Maxillofaciale · doi:10.1016/s1879-8551(11)70851-x · Cited by 2
Melmed, S. K. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-380926-1.10014-8 · Cited by 3
Balderrama-Soto, A., Rivera-Hernández, A. D. J., Reza‐Albarrán, A., Vergara-López, A., Monteros-Sánchez, A. L. E. D. L., González‐Virla, B., Pérez-Castañeda, C., Abreu-Rosario, C., Ramos, D. C., Cadena-Obando, D., et al. (2021) · Revista Mexicana de Endocrinología Metabolismo y Nutrición · doi:10.24875/rme.m21000007 · Cited by 2
Costanza, F., Giampietro, A., Marinis, L. D., Bianchi, A., Chiloiro, S., & Pontecorvi, A. (2025) · Targets · doi:10.3390/targets3030026 · Cited by 1
Self-citationOsteoporosis and fragility fractures in patients with acromegaly: A two-center cross-sectional study
Álvarez, M., Rincon, J., Ulloa, M. M., Rincón, O., Mejia, L., Alvarado, A., Pereira, A., & Bernal, M. (2025) · World Journal of Orthopedics · doi:10.5312/wjo.v16.i11.110420 · Cited by 1
Combination of multi-osteosynthesis devices for femoral trochanteric fracture of gigantism
Baba, T., Futamura, K., Aoki, K., Homma, Y., Shitoto, K., & Kaneko, K. (2014) · European Orthopaedics and Traumatology · doi:10.1007/s12570-014-0245-3 · Cited by 1
Acromegalic osteopathy: An update
Mazziotti, G., Frara, S., Formenti, A. M., Doga, M., Mortini, P., & Giustina, A. (2018) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2018.02.009 · Cited by 1
Self-citationArtritis reumatoide en paciente con acromegalia: un reto diagnóstico
Parra-Izquierdo, V., Cuervo, F. M., Tejada, M., & Mora, S. (2018) · Revista Argentina de Reumatología · doi:10.47196/rar.v29i1.541 · Cited by 1
Osteoporosis and arthropathy in functioning pituitary tumors
Claessen, K. M. J. A., Appelman‐Dijkstra, N. M., & Biermasz, N. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819949-7.00019-6 · Cited by 1
Challenging Questions in the Management of Acromegaly in the Young
Youssef, N., & Yuen, K. C. J. (2022) · Contemporary Endocrinology · doi:10.1007/978-3-031-16258-9_15 · Cited by 1
Prevalence of Vertebral Fractures and Serum Sclerostin Levels in AcromegalyPreprint
Uygur, M. M., Yazıcı, D., Buğdaycı, O., & Yavuz, D. G. (2021) · Research Square · doi:10.21203/rs.3.rs-233174/v1 · Cited by 1
Cormier, C. (2011) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(11)51199-0
AME P OSITION S TATEMENT ON CLINICAL MANA g EMENT O f ACROME g AL y
Papini, E. (2009)
Mortality and Morbidity in Acromegaly: Impact of Disease Control
Holdaway, I. M. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-317-6_16
Deficiencia y exceso de hormona de crecimiento y hueso
Muñoz, M. R., & Fernández, I. L. (2014) · Elsevier eBooks · doi:10.1016/b978-84-9022-503-5.00016-2
Neuroendocrinology of Bone Metabolism
Mazziotti, G., Doga, M., Formenti, A. M., Frara, S., Maffezzoni, F., & Giustina, A. (2017) · Endocrinology · doi:10.1007/978-3-319-38681-2_18-1
Self-citationGelenkbeteiligung bei Akromegalie
Patschan, S. A., Patschan, D., Raddatz, D., & Gollisch, K. S. C. (2018) · Aktuelle Rheumatologie · doi:10.1055/s-0043-122675
Frara, S., Maffezzoni, F., Doga, M., Formenti, A. M., Mazziotti, G., & Giustina, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-75110-8_6
Self-citationGrowth Hormone Producing Adenomas: Acromegaly
Liebert, K. J. P., Adelman, D. T., Rutten, E., & Yedinak, C. G. (2019) · Springer eBooks · doi:10.1007/978-3-319-99817-6_20
Plard, C., Hochman, C., Hadjadj, S., Goff, B. L., Maugars, Y., Cariou, B., Drui, D., & Guillot, P. (2021) · Revue du Rhumatisme · doi:10.1016/j.rhum.2021.02.001
Avaliação da microarquitetura óssea trabecular e cortical em adultos com diagnóstico de acromegalia
da Silva, P. P. B. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2020.tde-23072021-105126
Osteopatías fragilizantes endocrinas
Rochoux, Q., & Marcelli, C. (2021) · EMC - Aparato Locomotor · doi:10.1016/s1286-935x(21)45565-6
Research Activities Calendar - Research Division
shecanip (2011)
(2009) · Current Orthopaedic Practice · doi:10.1097/01.bco.0000360395.67521.c8
Neuroendocrinology of Bone Metabolism
Mazziotti, G., Doga, M., Formenti, A., Frara, S., Maffezzoni, F., & Giustina, A. (2018) · Endocrinology · doi:10.1007/978-3-319-44444-4_18
Self-citationEvaluation of Bone Mineral Densitometry Measurements in Newly Diagnosed Acromegaly Patients
Çalapkulu, M., Sencar, M. E., Ünsal, İ. Ö., Sakız, D., Bostan, H., Düğer, H., Özbek, M., & Çakal, E. (2022) · Turkish Journal of Osteoporosis · doi:10.4274/tod.galenos.2021.59489
Pituitary Adenomas: Classification, Clinical Evaluation and Management
Ibrahim, B., Mandel, M., Ali, A. M., Nájera, E., Obrzut, M., Adada, B., & Borghei-Razavi, H. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.103778
Musculoskeletal Disorders of Acromegaly
Feffer, J. B. (2022) · Contemporary Endocrinology · doi:10.1007/978-3-031-16258-9_9
Acromegaly versus hypogonadism: Bone fragility and evaluation
Sorohan, M. C., Baciu, I. F., Galoiu, S. A., Niculescu, D., Caragheorgheopol, A., Iordachescu, C. N., & Poiană, C. (2023) · Annales d Endocrinologie · doi:10.1016/j.ando.2023.08.005
Vertebral fractures in patients with non-functioning pituitary adenomas - a new frontier?
Tritos, N. A. (2024) · Pituitary · doi:10.1007/s11102-024-01413-z
Osteoporosis and Fractures in Patients with Acromegaly: A Two-Center Cross-Sectional StudyPreprint
Álvarez, M., Rincon, J., Ulloa, M. M., Rincón, O., Mejia, L., Alvarado, A., Bernal, M., & Galvis, A. (2024) · Research Square · doi:10.21203/rs.3.rs-4821632/v1
Clinical features of acromegaly
Popa-Ilie, I. R., & Korbonits, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00278-8
Multiple endocrine neoplasia syndromes
Newey, P. J., & Thakker, R. V. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13683-2.00033-5
Wang, X., Zhang, J., & Luo, Z. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2665524
Acromegalic osteoarthropathy: a new paradigm of pathological musculoskeletal remodeling
Mazziotti, G., Minisola, S., & CANALIS, E. M. (2026) · European Journal of Endocrinology · doi:10.1093/ejendo/lvag178
Self-citationOsteoporosi nelle malattie endocrine
Cianferotti, L., & Marcocci, C. (2009) · Springer eBooks · doi:10.1007/978-88-470-1357-5_13
Metadata
- Authors
- Mazziotti, G., Bianchi, A., Bonadonna, S., Cimino, V., Patelli, I., Fusco, A., Pontecorvi, A., De Marinis, L., & Giustina, A.
- Affiliations
- University of Brescia (IT)
- Università Cattolica del Sacro Cuore (IT)
- Corresponding author
- Giustina, Andrea
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-12
- Volume
- 93
- Issue
- 12
- Pages
- 4649-4655
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1979553864
- Cited by
- 169
- References
- 48
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 10 · 2023: 9 · 2022: 11 · 2021: 10 · 2020: 12 · 2019: 11 · 2018: 12 · 2017: 8 · 2016: 12 · 2015: 12 · 2014: 13 · 2013: 6 · 2012: 8
- FWCI
- 6.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Keywords
- acromegaly, vertebral fractures, osteoporosis, men, bone mineral density, insulin-like growth factor I, hypogonadism, disease duration, fracture risk factors
- MeSH terms
- Acromegaly, Adolescent, Adult, Aged, Aged, 80 and over, Cross-Sectional Studies, Female, Hip, Humans, Hypogonadism, Male, Middle Aged, Osteoporosis, Pituitary Hormones, Spinal Injuries, Absorptiometry, Photon, Bone Density, Logistic Models, Odds Ratio, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
